Donor screening
Despite challenges like emerging infectious threats, shortages, and budget constraints, precise and efficient testing are essential for a secure global blood supply.
Efficiency and excellence in every test
Understanding your budget and space constraints, our scalable instruments enhance efficiency by reducing storage, consumables, and instruments.
- Procleix assays tackle emerging infectious diseases, and simplify multi-infection testing, minimizing delays
- NAT testing expedites blood delivery, easing shortages.
- Our laboratory software streamlines operations through integration maximizing your resources
- Excellent service keeps your lab running smoothly
Together, we elevate blood safety and patient care standards in a dedicated partnership.
Pioneers in transfusion medicine
Our systems maximize your testing by giving you the best throughput per square meter of any system in donor screening.
The Past, Present and Future of NAT
Since the 1980s, Grifols has contributed to improving the safety and availability of transfused blood products.
Related Resources
Hepatitis E Blood Donor Screening: A Commitment to Transfusion Safety
Vector-borne agents in the US: An update on Zika virus and Babesia - AABB 2017
West Nile Virus in Europe - AABB 2017